U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07361120) titled 'Plan A Occlusion and Reversal System Feasibility Study' on Dec. 16, 2025.
Brief Summary: Prospective, multicenter, single-arm, open label, interventional clinical trial investigating the safety and effectiveness of the Plan A Male Contraceptive System to occlude the vas deferens to block the passage of sperm and then be reversed to subsequently allow the passage of sperm through the vas deferens.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Fertility
Fertility, Male
Healthy Male Adults
Intervention:
DEVICE: Occlusion System
The occlusion system comprised of the Delivery Lumen Access Device and Vasalgel....